Inhibition of insulin-like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival.
about
Inhibition of insulin-like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Inhibition of insulin-like gro ...... noma cell growth and survival.
@en
Inhibition of insulin-like gro ...... noma cell growth and survival.
@nl
type
label
Inhibition of insulin-like gro ...... noma cell growth and survival.
@en
Inhibition of insulin-like gro ...... noma cell growth and survival.
@nl
prefLabel
Inhibition of insulin-like gro ...... noma cell growth and survival.
@en
Inhibition of insulin-like gro ...... noma cell growth and survival.
@nl
P2093
P2860
P356
P1476
Inhibition of insulin-like gro ...... inoma cell growth and survival
@en
P2093
Annika Dalheim
Gregory Malnassy
Maribel Arteaga
Michael I Nishimura
Mitchell F Denning
Peter Breslin
Scott J Cotler
Thomas Bank
P2860
P304
P356
10.1002/HEP4.1181
P50
P577
2018-04-17T00:00:00Z